USA – AstraZeneca has announced that it will use Scorpion Therapeutics’ discovery platform to develop precision medicines against previously difficult-to-target cancer proteins. According to Susan Galbraith, AstraZeneca’s executive vice president…
Read MoreAstraZeneca forges deal with Scorpion Therapeutics worth US$1.6 billion
